Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Gabriela, Calamante"'
Autor:
María Paula Morelli, María Paula Del Medico Zajac, Joaquín Miguel Pellegrini, Nicolás Oscar Amiano, Nancy Liliana Tateosian, Gabriela Calamante, María Magdalena Gherardi, Verónica Edith García
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Mycobacterium tuberculosis (Mtb) infection is one of the leading causes of death worldwide. The Modified Vaccinia Ankara (MVA) vaccine vector expressing the mycobacterial antigen 85A (MVA85A) was demonstrated to be safe, although it did not improve B
Externí odkaz:
https://doaj.org/article/7553edbeb0a346fab78c0f7ff0d6f9ab
Autor:
Flavia Zanetti, Liliana Rudak, Matías Micucci, Daniela Conte Grand, Andrea Luque, Susana Russo, Oscar Taboga, Oscar Pérez, Gabriela Calamante
Publikováno v:
Revista Argentina de Microbiología, Vol 44, Iss 2, Pp 75-84 (2012)
En la Argentina, la rabia está circunscripta a algunas provincias del norte. La disponibilidad de nuevas vacunas que eliminen la manipulación del virus rábico y que permitan el control de la enfermedad es de importancia estratégica nacional y reg
Externí odkaz:
https://doaj.org/article/7aab84dd7b1643299aa4eb33037a2220
Publikováno v:
Molecular Plant-Microbe Interactions, Vol 14, Iss 11, Pp 1274-1285 (2001)
Tobacco plants were transformed with the open reading frame 3 gene from Potato virus X (PVX) coding for the p12 protein. Although the transgenic plants exhibited a normal morphological aspect, microscopic examination revealed extensive alterations in
Externí odkaz:
https://doaj.org/article/5dde3e43bbba4332a8e983073d2adfd3
Autor:
María Pía Holgado, Juliana Falivene, Cynthia Maeto, Micaela Amigo, María Fernanda Pascutti, María Belén Vecchione, Andrea Bruttomesso, Gabriela Calamante, María Paula del Médico-Zajac, María Magdalena Gherardi
Publikováno v:
Viruses, Vol 8, Iss 5, p 139 (2016)
MVA is an attenuated vector that still retains immunomodulatory genes. We have previously reported its optimization after deleting the C12L gene, coding for the IL-18 binding-protein. Here, we analyzed the immunogenicity of MVA vectors harboring the
Externí odkaz:
https://doaj.org/article/6b69fd1826a04d918577e118f2bd9b87
Autor:
María José Gravisaco, María Magdalena Gherardi, María Paula Del Medico Zajac, Gabriela Calamante, Gabriel Morón, Paula Molinari, Daniel Omar Maizon
Publikováno v:
Molecular immunology. 139
Modified vaccinia Ankara virus (MVA) is extensively used as a vaccine vector. We have previously observed that MVAΔ008, an MVA lacking the gene that codes for interleukin-18 binding protein, significantly increases CD8+ and CD4+ T-cell responses to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b651ecb97848737525a41099a6ac6ca
https://pubmed.ncbi.nlm.nih.gov/34481269
https://pubmed.ncbi.nlm.nih.gov/34481269
Autor:
Karam Allali, Yassine Amraouza, Saaid Amzazi, Paula N. Arrías, Virupaksha Ajit Bastikar, Mustapha Benhassou, Hlima Bessi, Gabriela Calamante, Santosh Subhash Chhajed, Federico Dapiaggi, María Paula Del Médico Zajac, Yassine El Mallali, Mohammed El Mzibri, Aissam El-Aliani, Moulay Mustapha Ennaji, Youssef Ennaji, M. Laura Fabre, Débora Garanzini, Pramodkumar Pyarelal Gupta, Jamal Hafid, Rahma Ait Hammou, Khalid Hattaf, Yassine Kasmi, Khadija Khataby, Shanker Lal Kothari, Maryame Lamsisi, Chafiqa Loutfi, Tomás Masson, Mahi M. Mohiuddin, Oscar Ramón Pérez, Matías L. Pidre, Stefano Pieraccini, Črtomir Podlipnik, Donatella Potenza, Víctor Romanowski, Darkaoui Sami, Herb E. Schellhorn, Amal Souiri, Francesca Vasile, Noura Yousfi, Mustapha Zemzami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fe90457d912439abb7a6b4be5d760d0
https://doi.org/10.1016/b978-0-12-814966-9.00027-5
https://doi.org/10.1016/b978-0-12-814966-9.00027-5
The “One Health” concept summarized the idea that the health both of human and animal is interdependent and is bound to the health of the ecosystems in which they exist. This notion is supported and implemented by the World Organization for Anima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a074032e04c75902859b2ca20f4876f0
https://doi.org/10.1016/b978-0-12-814966-9.00012-3
https://doi.org/10.1016/b978-0-12-814966-9.00012-3
Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein.
Autor:
Juliana Falivene, María Paula Del Médico Zajac, María Fernanda Pascutti, Ana María Rodríguez, Cynthia Maeto, Beatriz Perdiguero, Carmen E Gómez, Mariano Esteban, Gabriela Calamante, María Magdalena Gherardi
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e32220 (2012)
BACKGROUND: Modified Vaccinia Ankara (MVA) is an attenuated strain of Vaccinia virus (VACV) currently employed in many clinical trials against HIV/AIDS and other diseases. MVA still retains genes involved in host immune response evasion, enabling its
Externí odkaz:
https://doaj.org/article/1bc24610786648a684aef0e331e57445
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1581
Canarypox viruses (CNPV) are excellent candidates to develop recombinant vector vaccines due to both their capability to induce protective immune responses and their incompetence to replicate in mammalian cells (safety profile). In addition, CNPV and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c0a47704aa83e3349e45f8633d2055a
https://pubmed.ncbi.nlm.nih.gov/28374241
https://pubmed.ncbi.nlm.nih.gov/28374241
Publikováno v:
Methods in Molecular Biology ISBN: 9781493968671
Canarypox viruses (CNPV) are excellent candidates to develop recombinant vector vaccines due to both their capability to induce protective immune responses and their incompetence to replicate in mammalian cells (safety profile). In addition, CNPV and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea01f979276632c77a4cad9b3bc07831
https://doi.org/10.1007/978-1-4939-6869-5_2
https://doi.org/10.1007/978-1-4939-6869-5_2